Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis

[1]  B. Neuschwander‐Tetri,et al.  Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum , 2019, Hepatology.

[2]  Sarah E. Williams,et al.  A schizophrenia risk locus alters brain metal transport and plasma glycosylation , 2019, bioRxiv.

[3]  M. Arumugam,et al.  Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration , 2019, Journal of hepatology.

[4]  A. Dehghan,et al.  Effects of Genetically Determined Iron Status on Risk of Venous Thromboembolism and Carotid Atherosclerotic Disease: A Mendelian Randomization Study , 2019, Journal of the American Heart Association.

[5]  Roger Williams,et al.  Alcohol policy in the UK: where next? , 2019, The Lancet.

[6]  F. Tacke,et al.  Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.

[7]  J. Trotter,et al.  NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis , 2019, Hepatology.

[8]  Mary E. Haas,et al.  A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease , 2019, bioRxiv.

[9]  Z. Younossi Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.

[10]  A. Herlihy,et al.  Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver , 2018, PLoS ONE.

[11]  Laura J. Scott,et al.  Trans-ethnic association study of blood pressure determinants in over 750,000 individuals , 2018, Nature Genetics.

[12]  Jimmy D Bell,et al.  Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension , 2018, Diabetes.

[13]  C. Cruchaga,et al.  A missense variant in SLC39A8 is associated with severe idiopathic scoliosis , 2018, Nature Communications.

[14]  D. Nebert,et al.  Hepatic ZIP8 deficiency is associated with disrupted selenium homeostasis, liver pathology, and tumor formation. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[15]  J. Marchini,et al.  Genome-wide association studies of brain imaging phenotypes in UK Biobank , 2018, Nature.

[16]  S. Neubauer,et al.  Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial , 2018, PloS one.

[17]  M. Gee,et al.  Magnetic resonance enterography evaluation of Crohn disease activity and mucosal healing in young patients , 2018, Pediatric Radiology.

[18]  Jimmy D Bell,et al.  Reference range of liver corrected T1 values in a population at low risk for fatty liver disease—a UK Biobank sub-study, with an appendix of interesting cases , 2018, Abdominal Radiology.

[19]  G. Davey Smith,et al.  Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians , 2018, British Medical Journal.

[20]  Rachel M. Brown,et al.  Multiparametric magnetic resonance imaging for quantitation of liver disease: a two-centre cross-sectional observational study , 2018, Scientific Reports.

[21]  Dereje D. Jima,et al.  A Common Allele in FGF21 Associated with Sugar Intake Is Associated with Body Shape, Lower Total Body-Fat Percentage, and Higher Blood Pressure , 2018, Cell reports.

[22]  P. Visscher,et al.  Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.

[23]  Mohammad R. Ostovaneh,et al.  Association of Liver Fibrosis With Cardiovascular Diseases in the General Population: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2018, Circulation. Cardiovascular imaging.

[24]  J. Costas The highly pleiotropic gene SLC39A8 as an opportunity to gain insight into the molecular pathogenesis of schizophrenia , 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  B. Nordestgaard,et al.  Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals , 2018, European heart journal.

[26]  S. Mukhopadhyay Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14. , 2017, Neurotoxicology.

[27]  Mark Hudson,et al.  Guidelines on the management of abnormal liver blood tests , 2017, Gut.

[28]  Michael Brady,et al.  Deep Quantitative Liver Segmentation and Vessel Exclusion to Assist in Liver Assessment , 2017, MIUA.

[29]  C. Minelli,et al.  The Effect of Iron Status on Risk of Coronary Artery Disease: A Mendelian Randomization Study—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[30]  F. Shidfar,et al.  Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet , 2017, Biological Trace Element Research.

[31]  Tao Wang,et al.  Hepatic metal ion transporter ZIP8 regulates manganese homeostasis and manganese-dependent enzyme activity , 2017, The Journal of clinical investigation.

[32]  M. Robson,et al.  Multiparametric magnetic resonance imaging for the assessment of non‐alcoholic fatty liver disease severity , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[33]  Stefan Neubauer,et al.  Interobserver Variability in Histologic Evaluation of Liver Fibrosis Using Categorical and Quantitative Scores , 2017, American journal of clinical pathology.

[34]  T. Card,et al.  Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review. , 2017, The lancet. Gastroenterology & hepatology.

[35]  Stefan Neubauer,et al.  Characterisation of liver fat in the UK Biobank cohort , 2017, PloS one.

[36]  G. Ambler,et al.  Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: A cautionary note on a promising technique. , 2017, Journal of hepatology.

[37]  M. Robson,et al.  Reply to: "Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: A cautionary note on a promising technique". , 2017, Journal of hepatology.

[38]  Judy H. Cho,et al.  A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition. , 2016, Gastroenterology.

[39]  Stephen Burgess,et al.  PhenoScanner: a database of human genotype–phenotype associations , 2016, Bioinform..

[40]  Tom R. Gaunt,et al.  LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis , 2016, bioRxiv.

[41]  Samuel E. Jones,et al.  Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease , 2016, Diabetes.

[42]  Matthew D. Robson,et al.  Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease , 2016, Journal of hepatology.

[43]  Ellen M. Schmidt,et al.  New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk , 2016, Nature Communications.

[44]  Judy H. Cho,et al.  A pleiotropic missense variant in SLC 39 A 8 is associated with Crohn ’ s disease and human gut microbiome composition Short Title : SLC 39 A 8 associated with CD and gut microbiome , 2016 .

[45]  David M. Evans,et al.  Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis , 2015, Nature Genetics.

[46]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[47]  E. Speliotes,et al.  TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? , 2015, Gastroenterology.

[48]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[49]  Toshiko Tanaka,et al.  Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis , 2014, Nature Communications.

[50]  M. Robson,et al.  Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease , 2014, Journal of hepatology.

[51]  Chia-Ying Liu,et al.  Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). , 2013, Journal of the American College of Cardiology.

[52]  Nicholette D. Palmer,et al.  Characterization of european ancestry nonalcoholic fatty liver disease‐associated variants in individuals of african and hispanic descent , 2013, Hepatology.

[53]  B. Pierce,et al.  Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators , 2013, American journal of epidemiology.

[54]  P. Matthews,et al.  Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches , 2013, Journal of Cardiovascular Magnetic Resonance.

[55]  D. Nebert,et al.  ZIP8 regulates host defense through zinc-mediated inhibition of NF-κB. , 2013, Cell reports.

[56]  H. El‐Serag,et al.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[57]  Michael Charlton,et al.  The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. , 2012, Gastroenterology.

[58]  R. Wevers,et al.  Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. , 2012, American journal of human genetics.

[59]  Christian Gieger,et al.  Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma , 2011, Nature Genetics.

[60]  Udo Hoffmann,et al.  Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits , 2011, PLoS genetics.

[61]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[62]  Henrik,et al.  Association analyses of 249,796 individuals reveal eighteen new loci associated with body mass index , 2012 .

[63]  K. Lange,et al.  Prioritizing GWAS results: A review of statistical methods and recommendations for their application. , 2010, American journal of human genetics.

[64]  Jie Liu,et al.  Zinc supplementation reverses alcohol‐induced steatosis in mice through reactivating hepatocyte nuclear factor‐4α and peroxisome proliferator‐activated receptor‐α , 2009, Hepatology.

[65]  A. Hingorani,et al.  Nature's randomised trials , 2005, The Lancet.

[66]  T. Coates,et al.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.

[67]  R. Fisher,et al.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.

[68]  C. Day,et al.  Non‐alcoholic steatohepatitis: Definitions and pathogenesis , 2002, Journal of gastroenterology and hepatology.

[69]  K. Fox Hypertension and heart disease. , 1996, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[70]  H. Bremer,et al.  TWO CASES OF PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY , 1976, Acta paediatrica Scandinavica.

[71]  Sharma,et al.  Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis , 2022 .